| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer
1 company
Mary Reumuth last filed a Form 4 in October 2025, as Chief Financial Officer at KALA. From June 2020 to October 2025, the filings on record show 0 open-market purchases and 13 sales. Mary Reumuth's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Mary Reumuth a strong insider score of 77/100, based on 14 past trades. Over a 12-month horizon, 78.6% of those trades were profitable, with an average 12-month return of +48.2%.
At the last filing, the largest reported position was 28,906 shares of KALA. The KALA filings lean toward selling, a net 66,178 shares.
Shares as reported in the last Form 4 for each company; the most recent is from October 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 | KALA Kala Bio, Inc. | Chief Financial Officer | Sell | 2,850 | $1.30 | $3,705.00 | -2.1% | +0.8% | -33.7% | |
| Oct 26, 2021 | KALA Kala Bio, Inc. | Chief Financial Officer | Sell | 9,449 | $1.80 | $17,008.20 | -6.5% | -51.8% | -93.0% | |
| Jun 28, 2021 | KALA Kala Bio, Inc. | Chief Financial Officer | Sell | 2,452 | $5.77 | $14,148.04 | -1.7% | -46.6% | -93.9% |